These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38893834)

  • 1. Applying a Tripodal Hexaurea Receptor for Binding to an Antitumor Drug, Combretastatin-A4 Phosphate.
    Kong Y; Zhang R; Li B; Zhao W; Wang J; Sun XW; Lv H; Liu R; Tang J; Wu B
    Materials (Basel); 2024 May; 17(11):. PubMed ID: 38893834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Dependent phosphate separation using a tripodal hexaurea receptor.
    Sun ZY; Chen SQ; Liang L; Zhao W; Yang XJ; Wu B
    Chem Commun (Camb); 2023 Oct; 59(86):12923-12926. PubMed ID: 37823279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water-Soluble Combretastatin A4 Phosphate Orally Delivered via Composite Nanoparticles With Improved Inhibition Effect Toward S180 Tumors.
    Shen Y; Wu L; Qiu L
    J Pharm Sci; 2017 Oct; 106(10):3076-3083. PubMed ID: 28619603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic Charge-Neutral Anion Receptors for Reversible Binding and Release of Highly Hydrated Phosphate in Water.
    He M; Yao Y; Yang Z; Li B; Wang J; Wang Y; Kong Y; Zhou Z; Zhao W; Yang XJ; Tang J; Wu B
    Angew Chem Int Ed Engl; 2024 Aug; 63(33):e202406946. PubMed ID: 38802316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.
    Jiang H; Li ZP; Tian GX; Pan RY; Xu CM; Zhang B; Wu JL
    Int J Nanomedicine; 2019; 14():1789-1804. PubMed ID: 30880980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Drug Combretastatin-A4 Phosphate Aggravates the Symptoms of Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
    Tang Z; Xiong D; Song J; Ye M; Liu J; Wang Z; Zhang L; Xiao X
    Front Pharmacol; 2020; 11():339. PubMed ID: 32265711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanogel-Incorporated Injectable Hydrogel for Synergistic Therapy Based on Sequential Local Delivery of Combretastatin-A4 Phosphate (CA4P) and Doxorubicin (DOX).
    Yang WJ; Zhou P; Liang L; Cao Y; Qiao J; Li X; Teng Z; Wang L
    ACS Appl Mater Interfaces; 2018 Jun; 10(22):18560-18573. PubMed ID: 29767951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance reversal by combretastatin-A4 phosphate loaded with doxorubicin in polymersomes independent of angiogenesis effect.
    Zhu J; Hu M; Qiu L
    J Pharm Pharmacol; 2017 Jul; 69(7):844-855. PubMed ID: 28425588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma.
    Zhu J; Xu X; Hu M; Qiu L
    J Biomed Nanotechnol; 2015 Jun; 11(6):997-1006. PubMed ID: 26353589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-Induced J-Aggregate Formation Causes a Biphasic Change in the Release of trans-Combretastatin A4 Disodium Phosphate from Archaeosomes and the Subsequent Cytotoxicity on Mammary Cancer Cells.
    Daswani VP; Ayesa U; Venegas B; Chong PL
    Mol Pharm; 2015 Oct; 12(10):3724-34. PubMed ID: 26355665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Anticancer Effects of Cisplatin Combined with Combretastatin A4 Phosphate on Human Osteosarcoma-Xenografted Mice.
    Dai G; Zheng D; Liu G; Song Q
    Cells Tissues Organs; 2021; 210(4):293-300. PubMed ID: 34433168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, excretion, and distribution of combretastatin A4 phosphate in rats.
    Xu XP; Wu XD; Liang GL; Huang WS; Wang L; Jing HY; Zhong SL
    Pharmazie; 2012 Jun; 67(6):529-33. PubMed ID: 22822542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halogen Bonding Tripodal Metallo-Receptors for Phosphate Recognition and Sensing in Aqueous-Containing Organic Media.
    Bagha H; Hein R; Lim JYC; Durr CB; Sambrook MR; Beer PD
    Chemistry; 2024 Jan; 30(2):e202302775. PubMed ID: 37792284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma.
    Badn W; Kalliomäki S; Widegren B; Sjögren HO
    Clin Cancer Res; 2006 Aug; 12(15):4714-9. PubMed ID: 16899622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate.
    Kirwan IG; Loadman PM; Swaine DJ; Anthoney DA; Pettit GR; Lippert JW; Shnyder SD; Cooper PA; Bibby MC
    Clin Cancer Res; 2004 Feb; 10(4):1446-53. PubMed ID: 14977848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
    Lian B; Wei H; Pan R; Sun J; Zhang B; Wu J; Li X; Tian G
    Int J Nanomedicine; 2021; 16():457-467. PubMed ID: 33488080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model.
    Gao M; Zhang D; Jin Q; Jiang C; Wang C; Li J; Peng F; Huang D; Zhang J; Song S
    Oncotarget; 2016 Sep; 7(36):58133-58141. PubMed ID: 27531898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse micelles-in-microspheres with sustained release of water-soluble combretastatin A4 phosphate for S180 tumor treatment.
    Wu L; Qiu L
    J Mater Chem B; 2016 Jan; 4(4):760-767. PubMed ID: 32262957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a rapid and sensitive LC-MS/MS assay for the determination of combretastatin A4 phosphate, combretastatin A4 and combretastatin A4 glucuronide in beagle dog plasma and its application to a pharmacokinetic study.
    Wang X; Chen Z; Che J; Meng Q; Shan C; Hou Y; Liu X; Chai Y; Cheng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3813-21. PubMed ID: 19822461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Ideal
    Portis B; Mirchi A; Emami Khansari M; Pramanik A; Johnson CR; Powell DR; Leszczynski J; Hossain MA
    ACS Omega; 2017 Sep; 2(9):5840-5849. PubMed ID: 28983526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.